Analysis of Frailty in Geriatric Patients as a Prognostic Factor in Endovascular Treated Patients with Large Vessel Occlusion Strokes
Autor: | Marios-Nikos Psychogios, Christian Heiner Riedel, Ilko Maier, Jan Liman, Mathias Bähr, Alex Brehm, Mareike Kirsch, Christine A. F. von Arnim, Daniel Behme, Marlena Schnieder |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Prognostic factor frailty 030204 cardiovascular system & hematology elderly patients Article mechanical thrombectomy 03 medical and health sciences 0302 clinical medicine Modified Rankin Scale Internal medicine medicine In patient 030212 general & internal medicine Stroke Framingham Risk Score business.industry General Medicine medicine.disease stroke hospital frailty risk score 3. Good health Cohort Medicine business Large vessel occlusion Cohort study |
Zdroj: | Journal of Clinical Medicine, Vol 10, Iss 2171, p 2171 (2021) Journal of Clinical Medicine Volume 10 Issue 10 |
ISSN: | 2077-0383 |
DOI: | 10.3390/jcm10102171 |
Popis: | Frailty is associated with an increased risk of adverse health-care outcomes in elderly patients. The Hospital Frailty Risk Score (HFRS) has been developed and proven to be capable of identifying patients which are at high risk of adverse outcomes. We aimed to investigate whether frail patients also face adverse outcomes after experiencing an endovascular treated large vessel occlusion stroke (LVOS). In this retrospective observational cohort study, we analyzed patients ≥ 65 years that were admitted during 2015–2019 with LVOS and endovascular treatment. Primary outcomes were mortality and the modified Rankin Scale (mRS) after three months. Regression models were used to determine the impact of frailty. A total of 318 patients were included in the cohort. The median HFRS was 1.6 (IQR 4.8). A total of 238 (75.1%) patients fulfilled the criteria for a low-frailty risk with a HFRS < 5.72 (22.7%) for moderate-frailty risk with an HFRS from 5–15 and 7 (2.2%) patients for a high-frailty risk. Multivariate regression analyses revealed that the HFRS was associated with an increased mortality after 90 days (CI (95%) 1.001 to 1.236 OR 1.112) and a worse mRS (CI (95%) 1.004 to 1.270 OR 1.129). We identified frailty as an impact factor on functional outcome and mortality in patients undergoing thrombectomy in LVOS. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |